Shandong Xinhua Pharmaceutical Co Ltd ($719) - buy or sell? Stock discussion, ideas, forum

Shandong Xinhua Pharmaceutical Co Ltd

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and markets bulk pharmaceuticals, preparations, and chemical products.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$719	HKEx Main Board	CNE100000411	Code: 719

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 719 stock

Share your investment idea or question on Shandong Xinhua Pharmaceutical Co Ltd stock:

Latest twits on Shandong Xinhua Pharmaceutical Co Ltd (719)

No twits yet. Be the first to post!

Have a question about 719? Ask and other investors will be eager to help you.

Have an idea about 719? Share it with other investors.

Shandong Xinhua Pharmaceutical Co Ltd news

14/03/2017 Shandong Xinhua Pharmaceutical Co Ltd reports 34.3% CAPEX growth and 11.1% Revenue growth

30/03/2016 Shandong Xinhua Pharmaceutical Co Ltd Debt surged on 19.4% in 2015 and Revenue increased slightly on 0.96%

Shandong Xinhua Pharmaceutical Co Ltd stock price chart

Shandong Xinhua Pharmaceutical Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	2,589	2,918	2,932
EBITDA	300.5	305.9	236.3
Net income	101.3	74.375	22.417
CAPEX	214.8	466.9	573.9
Debt	475.5	688.5	1,211
Cash	368.1	268.0	375.5

Shandong Xinhua Pharmaceutical Co Ltd news

About Shandong Xinhua Pharmaceutical Co Ltd

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and markets bulk pharmaceuticals, preparations, and chemical products. Bulk pharmaceutical products include antipyretic, analgesic, antiseptic, and central nervous system medicines.